Experts protect the ability of customized medicine for hereditary breast cancer

Breast cancer experts highlighted The impact of the development of medicine Customized in the medical, prevention and therapeutic approach of genetic prognosis for this type Cancer.

This is one of the central theme of the XI day in the hereditary breast cancer organized by Thursday Barcelona Grubo Choli and Spanish Group Breast Cancer Research (Geicam) Spanish Society of Medical oncology (SEOM)They report to the drivers in a statement.

This meeting has merged more than 100 experts relating to cancer management, they have shown The importance of developing technologies and growing practices Treatment strategies for each patient and the specified situation and more accurately.

Although representing minority cases between 5% and 10%, hereditary breast cancer (CMH) has medical impacts “Especially appropriate”: Patients are generally younger, bilateral or many primary tumors and may require specific preventive and treatment strategies.

In addition, a sprout is identified by the pathogenic variation A “direct” impact on the familyKnowing this information will benefit many members by the Genetic Council programs and surveillance.

With an agenda that focuses on the medical activity of genetic knowledge, The development of new predisposition tools And the coordination of the directed treatment, this phenomenon has revealed the “possibility” of accurate medicine in this line.

It also includes tables with patient associations, A medical case competition aimed at young experts To share real experiences and workshops in “major” aspects such as genetic consultation or management of cases called ‘moderate risk’.